Trial Profile
Clinical Trials Insight: 700028379
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Nov 2007
Price :
$35
*
At a glance
- Drugs FT 105 (Primary) ; Insulin glargine
- Indications Diabetes mellitus; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Flamel Technologies
- 13 Nov 2007 New trial record.
- 19 Oct 2007 Preliminary results reported in a Falmel Technologies media release.